biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Tough time in the market now...

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Feb 24, 2023 11:28am

54 Views

Post# 35303443

RE:RE:RE:Tough time in the market now...

The Bioasis share price of 1.5¢ was not caused by the market nonsense you describe, poof.

The S&P ETFs are not down 95% over the last 4 years like Bioasis is.

You and Bioasis seem to think that Bioasis shareholders will believe anything just because you said so.

Got news for you and Bioasis, poof. The shareholders have it all figured out. They believe that Bioasis has been almost destroyed by incompetence and/or by design, and you're blaming it on the market.

jd

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season